Q4 2022 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Q4 and FY '22 Conference Call of Eris Life Sciences. We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you sir.
Thank you. Good afternoon, and welcome to our fourth quarter conference call. I'm Krishnakumar, and I'm happy to connect with you today. At the outset, I'm delighted to inform you that Eris has entered the elite club of Indian pharma companies to have crossed INR 400 crores of profit after tax in just 15 years from inception. There are less than a handful of pharma companies in these categories. We have delivered an EPS growth of 14% in this financial year on the back of a 21% EPS growth, which we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
